Cargando…
Quercetin Is a Flavonoid Breast Cancer Resistance Protein Inhibitor with an Impact on the Oral Pharmacokinetics of Sulfasalazine in Rats
The potential inhibitory effect of quercetin, a major plant flavonol, on breast cancer resistance protein (BCRP) activity was investigated in this study. The presence of quercetin significantly increased the cellular accumulation and associated cytotoxicity of the BCRP substrate mitoxantrone in huma...
Autores principales: | Song, Yoo-Kyung, Yoon, Jin-Ha, Woo, Jong Kyu, Kang, Ju-Hee, Lee, Kyeong-Ryoon, Oh, Seung Hyun, Chung, Suk-Jae, Maeng, Han-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285070/ https://www.ncbi.nlm.nih.gov/pubmed/32357395 http://dx.doi.org/10.3390/pharmaceutics12050397 |
Ejemplares similares
-
Negligible Effect of Quercetin in the Pharmacokinetics of Sulfasalazine in Rats and Beagles: Metabolic Inactivation of the Interaction Potential of Quercetin with BCRP
por: Oh, Ju-Hee, et al.
Publicado: (2021) -
Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells
por: Chae, Yoon-Jee, et al.
Publicado: (2021) -
Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats
por: Song, Yoo-Kyung, et al.
Publicado: (2021) -
Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models
por: Oh, Ju-Hee, et al.
Publicado: (2019) -
Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans
por: Jeong, Yoo-Seong, et al.
Publicado: (2021)